Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development ...

Stock futures dipped early Friday morning as investors geared up to closely monitor new personal spending and inflation data. These economic indicators could of ...

The US FDA has approved Bristol Myers Squibb’s oral medicine, Cobenfy, for treating schizophrenia in adults. This is the ...

Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...

The global titanium dioxide color market is forecast to expand at 3% CAGR over the estimated period, as per FMI’s analysis. The industry’s size is predicted to surge from USD 34 million in 2023 to USD ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Nationally, Sen. Ron Wyden, an Oregon Democrat, has introduced the Cannabinoid Safety and Regulation Act to direct the Food & ...

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

MedStar executive Raj Ratwani says the idea of shared responsibility should be central to how health AI is regulated.

Biotin and collagen are nutrients that support hair, skin, nail, and bone health. A healthcare provider may suggest taking ...

Tagrisso, which targets exon 19 deletions or exon 21 (L858R) mutations, received the approval following a priority review.